Home/OCON Therapeutics/Amir Avraham
AA

Amir Avraham

Chief Financial Officer & General Manager

OCON Therapeutics

OCON Therapeutics Pipeline

DrugIndicationPhase
IUB® BALLERINE®Hormone‑free contraceptionPhase 2
IUB® SEAD®Abnormal uterine bleeding / heavy menstrual bleedingPhase 2
IUB® PRIMA®Endometriosis, uterine fibroids, hormonal disordersPre‑clinical